Search | TVST | ARVO Journals

Showing 1 – 20 of 49

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Articles August 2019

Conjunctival HLA-DR Expression and Its Association With Symptoms and Signs in the DREAM Study

PDF

Neeta S. Roy; Yi Wei; Yinxi Yu; Gui-Shuang Ying; Eric Kuklinski; Brendan Barry; Maureen G. Maguire; Reza Dana; Mary Brightwell-Arnold; Penny A. Asbell; for the Dry Eye Assessment and Management (DREAM) Study Group
TAGS: conjunctiva, dreams, hla-dr antigens, human leukocyte antigens, signs and symptoms, electroconvulsive therapy, epidural cortical stimulation, mandibulofacial dysostosis
Trans. Vis. Sci. Tech.. 2019; 8(4):31. doi: 10.1167/tvst.8.4.31

ARVO Annual Meeting Abstract July 2019

Longitudinal Trends in Antibiotic Resistance Among Staphylococci Collected in the ARMOR Study

Penny A Asbell; Christine M Sanfilippo; Heleen H DeCory

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):853. doi:

ARVO Annual Meeting Abstract July 2019

DREAM Extension Study - Comparison of placebo and omega-3 fatty acid supplement groups on OSDI, 4 key signs of DED and adverse events

Munira Hussain; Roni M Shtein; Maxwell Pistilli; Maureen G Maguire; Penny A Asbell

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6729. doi:

ARVO Annual Meeting Abstract July 2019

Determinants of Ocular Discomfort Severity Among Participants in the Dry Eye Assessment and Management (DREAM) Study

Rony R Sayegh; Maureen G Maguire; Yinxi Yu; John Farrar; Roni M Shtein; Eric Kuklinski; Penny A Asbell

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6747. doi:

ARVO Annual Meeting Abstract July 2019

Can Participation in Virtual Patient Simulation Improve Dry Eye Diagnosis and Management?

Siggi Trier; Douglas Blevins; Peter Schoonheim; Stefano Barabino; Penny A Asbell

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2769. doi:

ARVO Annual Meeting Abstract July 2019

Antibiotic Resistance Among Ocular Pathogens – An Update from the 2018 ARMOR Study

Christine M Sanfilippo; Heleen H DeCory; Penny A Asbell

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):246. doi:

ARVO Annual Meeting Abstract July 2019

Comparison of Clinical and Reading Center Assessments of Meibomian Glands in the Dry Eye Assessment and Management (DREAM) Study

Maxwell Pistilli; Maureen G Maguire; Ebenezer Daniel; Vatinee Y Bunya; Mina Massaro-Giordano; Eli Smith; Pooja Kadakia; Penny A Asbell

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6778. doi:

ARVO Annual Meeting Abstract July 2019

Grading and Baseline Characteristics of Meibomian Glands using Meibography images in the Dry Eye Assessment and Management (DREAM) Trial

Ebenezer Daniel; Maureen G Maguire; Maxwell Pistilli; Vatinee Y Bunya; Giacomina Massaro-giordano; Eli Smith; Pooja Kadakia; Penny A Asbell

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6783. doi:

ARVO Annual Meeting Abstract July 2019

Exploratory Outcome Measures of the DRy Eye Assessment and Management (DREAM) Study

Marko Oydanich; Jack V Greiner; Pedram Hamrah; Meng C Lin; Maxwell Pistilli; Maureen G Maguire; Gui-Shuang Ying; Penny A Asbell

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5208. doi:

ARVO Imaging in the Eye Conference Abstract August 2019

Predicting the likelihood of future keratoplasty from imaging corneal parameters using manifold learning

Siamak Yousefi; hidenori takahashi; Takahiko Hayashi; Hironobu Tampo; Satoru Inoda; Yusuke Arai; Penny Asbell

Invest. Ophthalmol. Vis. Sci.. 2019; 60(11):PB0141. doi:

ARVO Annual Meeting Abstract July 2018

Conjunctival epithelial cell HLA-DR expression and association with signs and symptoms of Dry Eye Disease (DED) in the ‘Dry Eye Assessment and Management’ (DREAM © ) Study.

Neeta S Roy; Yi Wei; Eric Kuklinski; Brendan Barry; Gui-Shuang Ying; Yinxi Yu; Maureen G. Maguire; Mary Brightwell-Arnold; Penny A Asbell

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):919. doi:

ARVO Annual Meeting Abstract July 2018

Prevalence of Novel Candidate Sjogren's Syndrome Antibodies in the Dry Eye Assessment and Management (DREAM © ) Study

Vatinee Y Bunya; Gui-Shuang Ying; Maureen G. Maguire; Eric Kuklinski; Ellen Peskin; Meng C Lin; Penny A Asbell

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):937. doi:

ARVO Annual Meeting Abstract July 2018

Correlation of clinical and keratographic assessments of tear stability and tear production at baseline in the DRy Eye Assessment and Management (DREAM © ) Study

Yinxi Yu; Ellie Schmucker; Maureen G. Maguire; John E Sutphin; Penny A Asbell

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3785. doi:

ARVO Annual Meeting Abstract July 2018

The Association between Signs and Symptoms in Patients with Dry Eye Disease

Maxwell Pistilli; Maureen G. Maguire; Jack V Greiner; Penny A Asbell

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):924. doi:

ARVO Annual Meeting Abstract July 2018

Association of systemic omega-3 fatty acids with dry eye signs and symptoms at baseline in the DRy Eye Assessment and Management (DREAM © ) Study

Eric Kuklinski; Milton M Hom; Maureen G. Maguire; Gui-Shuang Ying; Meng C Lin; Robert Chapkin; Penny A Asbell

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4880. doi:

ARVO Annual Meeting Abstract July 2018

Antibiotic Resistance in Ocular Pathogens – Preliminary Results from the 2017 ARMOR Surveillance Program

Christine M Sanfilippo; Megan E Cavet; Heleen DeCory; Penny A Asbell

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2659. doi:

ARVO Annual Meeting Abstract July 2018

Antibiotic Resistance Trends Among Staphylococci in the ARMOR Study: 2009-2017

Penny A Asbell; Christine M Sanfilippo; Megan E Cavet; Heleen DeCory

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3676. doi:

Clinical and Epidemiologic Research May 2018

Clinical Outcomes of Fixed Versus As-Needed Use of Artificial Tears in Dry Eye Disease: A 6-Week, Observer-Masked Phase 4 Clinical Trial

PDF

Penny Asbell; Algis J. Vingrys; Jacqueline Tan; Abayomi Ogundele; Laura E. Downie; Gary Jerkins; Lee Shettle
TAGS: phase iv trial, dry eye syndromes, treatment outcome, ocular lubricants
Invest. Ophthalmol. Vis. Sci.. 2018; 59(6):2275-2280. doi: 10.1167/iovs.17-23733

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2017

Antibiotic Resistance in Ocular Pathogens – An Update from the 2016 ARMOR Surveillance Program

Christine M Sanfilippo; Heleen H DeCory; Daniel F Sahm; Penny A Asbell

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1083. doi:

ARVO Annual Meeting Abstract June 2017

Fixed versus pro-re-nata dosing of polyethylene glycol/propylene glycol-based artificial tears: A randomized clinical trial

Penny A Asbell; Algis J Vingrys; Jacqueline Tan; Philip Lee Shettle; Eugene B McLaurin; Abayomi Ogundele; Laura Elizabeth Downie; Gary Jenkins

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2685. doi:

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Conjunctival HLA-DR Expression and Its Association With Symptoms and Signs in the DREAM Study

Longitudinal Trends in Antibiotic Resistance Among Staphylococci Collected in the ARMOR Study

DREAM Extension Study - Comparison of placebo and omega-3 fatty acid supplement groups on OSDI, 4 key signs of DED and adverse events

Determinants of Ocular Discomfort Severity Among Participants in the Dry Eye Assessment and Management (DREAM) Study

Can Participation in Virtual Patient Simulation Improve Dry Eye Diagnosis and Management?

Antibiotic Resistance Among Ocular Pathogens – An Update from the 2018 ARMOR Study

Comparison of Clinical and Reading Center Assessments of Meibomian Glands in the Dry Eye Assessment and Management (DREAM) Study

Grading and Baseline Characteristics of Meibomian Glands using Meibography images in the Dry Eye Assessment and Management (DREAM) Trial

Exploratory Outcome Measures of the DRy Eye Assessment and Management (DREAM) Study

Predicting the likelihood of future keratoplasty from imaging corneal parameters using manifold learning

Conjunctival epithelial cell HLA-DR expression and association with signs and symptoms of Dry Eye Disease (DED) in the ‘Dry Eye Assessment and Management’ (DREAM © ) Study.

Prevalence of Novel Candidate Sjogren's Syndrome Antibodies in the Dry Eye Assessment and Management (DREAM © ) Study

Correlation of clinical and keratographic assessments of tear stability and tear production at baseline in the DRy Eye Assessment and Management (DREAM © ) Study

The Association between Signs and Symptoms in Patients with Dry Eye Disease

Association of systemic omega-3 fatty acids with dry eye signs and symptoms at baseline in the DRy Eye Assessment and Management (DREAM © ) Study

Antibiotic Resistance in Ocular Pathogens – Preliminary Results from the 2017 ARMOR Surveillance Program

Antibiotic Resistance Trends Among Staphylococci in the ARMOR Study: 2009-2017

Clinical Outcomes of Fixed Versus As-Needed Use of Artificial Tears in Dry Eye Disease: A 6-Week, Observer-Masked Phase 4 Clinical Trial

Antibiotic Resistance in Ocular Pathogens – An Update from the 2016 ARMOR Surveillance Program

Fixed versus pro-re-nata dosing of polyethylene glycol/propylene glycol-based artificial tears: A randomized clinical trial

To View More...

You must be signed into an individual account to use this feature.